Acura Pharmaceuticals, Inc. Stock
Stocks
ACUR
US00509L8028
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000200 USD | +100.00% |
|
-77.78% | -60.00% |
| 06-23 | Acura Pharmaceuticals, Inc. announced that it has received $0.2 million in funding | CI |
| 05-28 | Acura Pharmaceuticals, Inc. announced that it has received $0.1 million in funding | CI |
| Market Cap | 3.28M 2.87M 2.65M 2.44M 4.64M 313M 4.71M 31.6M 12.41M 154M 12.31M 12.04M 530M | P/E 2020 |
-5.25x | P/E 2021 | -25x |
|---|---|---|---|---|---|
| Enterprise Value | 3.41M 2.99M 2.75M 2.54M 4.83M 326M 4.91M 32.91M 12.92M 160M 12.82M 12.54M 551M | EV / Sales 2020 |
2.91x | EV / Sales 2021 | 20.9x |
| Free-Float |
98.31% | Yield 2020 * |
-
| Yield 2021 | - |
| 1 day | +100.00% | ||
| 1 week | -77.78% | ||
| Current month | -77.78% | ||
| 6 months | -60.00% | ||
| Current year | -60.00% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0.01 |
| 1 year | 0 | | 0.01 |
| 3 years | 0 | | 0.75 |
| 5 years | 0 | | 0.75 |
| 10 years | 0 | | 2.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 67 | 2011-03-31 |
Bob Seiser
DFI | Director of Finance/CFO | 62 | 2024-07-31 |
Albert Brzeczko
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
William Skelly
CHM | Chairman | 75 | 1996-09-30 |
| Director/Board Member | 55 | 2002-11-30 | |
Bruce Wesson
BRD | Director/Board Member | 83 | 1998-02-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-01 | Fiscal year | Director | 150,000 | 0.2273% | ||
| 01-01 | Fiscal year | Director | 150,000 | 0.2273% | ||
| 01-01 | Fiscal year | Director | 150,000 | 0.2273% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +100.00% | -77.78% | 0.00% | -33.33% | 13.33K | |
| -4.14% | -8.06% | +57.35% | +117.24% | 54.63B | |
| +1.84% | -0.66% | +75.79% | +93.87% | 54.88B | |
| -2.24% | +3.59% | +19.60% | +466.72% | 25.06B | |
| -1.60% | -6.21% | -19.69% | -14.84% | 23.14B | |
| +2.43% | +1.06% | +47.70% | -0.11% | 19.88B | |
| -3.19% | 0.00% | +33.99% | -26.87% | 17.55B | |
| -6.84% | +2.18% | +195.12% | +357.18% | 16.5B | |
| -1.05% | +1.16% | +25.08% | +196.28% | 14.2B | |
| +8.74% | +3.51% | +53.81% | - | 15.36B | |
| Average | +9.40% | -0.25% | +48.88% | +128.46% | 24.12B | |
| Weighted average by Cap. | -0.91% | -1.46% | +55.04% | +137.79% |
| 2020 | 2021 | |
|---|---|---|
| Net sales | 3.57M 3.12M 2.88M 2.66M 5.05M 340M 5.13M 34.41M 13.51M 168M 13.4M 13.11M 577M | 1.56M 1.37M 1.26M 1.16M 2.21M 149M 2.25M 15.07M 5.92M 73.44M 5.87M 5.74M 252M |
| Net income | -1.21M -1.06M -975K -900K -1.71M -115M -1.74M -11.64M -4.57M -56.76M -4.54M -4.44M -195M | -879K -769K -709K -655K -1.24M -83.83M -1.26M -8.47M -3.33M -41.3M -3.3M -3.23M -142M |
| Net Debt | 5.86M 5.12M 4.72M 4.36M 8.28M 559M 8.42M 56.45M 22.17M 275M 21.99M 21.51M 946M | 135K 118K 109K 101K 191K 12.88M 194K 1.3M 511K 6.34M 507K 496K 21.81M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | US$0.000200 | +100.00% | 2,126 |
| 26-07-09 | US$0.000100 | +9,900.00% | 500 |
- Stock Market
- Stocks
- ACUR Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
